Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine

Rizzetto, 1977, Immunofluorescence detection of a new antigen-antibody system delta/anti-delta associated to the hepatitis B virus in the liver and the serum of HBs-Ag carriers, Gut, 18, 997, 10.1136/gut.18.12.997 Hsieh, 2006, Natural course and treatment of hepatitis D virus infection, J Formos Med Assoc, 105, 869, 10.1016/S0929-6646(09)60172-8 Farci, 2003, Delta hepatitis: an update, J Hepatol, 39, S212, 10.1016/S0168-8278(03)00331-3 Castelnau, 2006, Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up, Hepatology, 44, 728, 10.1002/hep.21325 Le Gal, 2005, Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients, J Clin Microbiol, 43, 2363, 10.1128/JCM.43.5.2363-2369.2005 Radjef, 2004, Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a Deltavirus genus of at least seven major clades, J Virol, 78, 2537, 10.1128/JVI.78.5.2537-2544.2004 Williams, 2009, Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene, J Gen Virol, 90, 2759, 10.1099/vir.0.011239-0 Bozdayi, 2004, Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients, Arch Virol, 149, 2115, 10.1007/s00705-004-0363-2 Farci, 2004, Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis, Gastroenterology, 126, 1740, 10.1053/j.gastro.2004.03.017 Gozlan, 2009, Complete cure of HBV-HDV co-infection after 24 weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV, J Hepatol, 50, 432, 10.1016/j.jhep.2008.05.029 Van Bömmel, 2004, Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection, Hepatology, 40, 1421, 10.1002/hep.20464 Wursthorn, 2006, Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B, Hepatology, 44, 675, 10.1002/hep.21282